PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 83 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50 | -18.0% | 19,285 | +11.2% | 0.00% | – |
| Q2 2023 | $61 | +13.0% | 17,340 | +0.2% | 0.00% | – |
| Q1 2023 | $54 | -26.0% | 17,298 | 0.0% | 0.00% | – |
| Q4 2022 | $73 | -99.9% | 17,298 | -68.0% | 0.00% | – |
| Q3 2022 | $129,000 | -20.9% | 54,110 | -5.2% | 0.00% | – |
| Q2 2022 | $163,000 | -9.9% | 57,066 | -8.4% | 0.00% | – |
| Q1 2022 | $181,000 | -65.6% | 62,308 | -64.1% | 0.00% | – |
| Q4 2021 | $526,000 | +17.9% | 173,374 | +172.4% | 0.00% | – |
| Q3 2021 | $446,000 | -3.7% | 63,643 | +25.9% | 0.00% | – |
| Q2 2021 | $463,000 | -25.9% | 50,531 | -21.5% | 0.00% | – |
| Q1 2021 | $625,000 | -22.8% | 64,349 | -18.5% | 0.00% | – |
| Q4 2020 | $810,000 | -21.5% | 78,932 | -22.8% | 0.00% | -100.0% |
| Q3 2020 | $1,032,000 | -12.5% | 102,215 | -9.7% | 0.00% | 0.0% |
| Q2 2020 | $1,180,000 | +36.6% | 113,161 | +10.5% | 0.00% | 0.0% |
| Q1 2020 | $864,000 | +8.0% | 102,431 | +12.0% | 0.00% | – |
| Q4 2019 | $800,000 | -22.5% | 91,432 | -4.7% | 0.00% | -100.0% |
| Q3 2019 | $1,032,000 | +35.3% | 95,975 | +59.9% | 0.00% | – |
| Q2 2019 | $763,000 | -39.4% | 60,030 | +84.9% | 0.00% | -100.0% |
| Q1 2019 | $1,259,000 | +62.7% | 32,463 | -14.7% | 0.00% | – |
| Q4 2018 | $774,000 | -87.1% | 38,059 | -70.9% | 0.00% | -100.0% |
| Q3 2018 | $6,003,000 | +43.7% | 130,911 | +85.4% | 0.00% | 0.0% |
| Q2 2018 | $4,177,000 | +242.9% | 70,624 | +294.7% | 0.00% | +300.0% |
| Q1 2018 | $1,218,000 | -91.5% | 17,891 | -87.7% | 0.00% | -91.7% |
| Q4 2017 | $14,383,000 | -44.8% | 145,505 | -33.1% | 0.01% | -55.6% |
| Q3 2017 | $26,065,000 | +110.8% | 217,649 | +53.9% | 0.03% | +92.9% |
| Q2 2017 | $12,364,000 | +388.3% | 141,462 | +107.8% | 0.01% | +366.7% |
| Q1 2017 | $2,532,000 | +776.1% | 68,062 | +623.4% | 0.00% | – |
| Q4 2016 | $289,000 | +1056.0% | 9,409 | +2395.8% | 0.00% | – |
| Q3 2016 | $25,000 | -78.3% | 377 | -90.5% | 0.00% | – |
| Q1 2016 | $115,000 | +105.4% | 3,961 | +453.2% | 0.00% | – |
| Q4 2015 | $56,000 | -97.1% | 716 | -97.2% | 0.00% | -100.0% |
| Q3 2015 | $1,940,000 | -83.5% | 25,855 | -74.5% | 0.00% | -84.6% |
| Q2 2015 | $11,740,000 | +195.4% | 101,208 | +501.1% | 0.01% | +225.0% |
| Q1 2015 | $3,974,000 | -31.6% | 16,838 | -45.2% | 0.00% | -33.3% |
| Q4 2014 | $5,811,000 | -77.2% | 30,742 | -71.3% | 0.01% | -75.0% |
| Q3 2014 | $25,481,000 | +65.8% | 107,065 | -54.0% | 0.02% | +50.0% |
| Q2 2014 | $15,367,000 | +2286.2% | 232,827 | +3660.7% | 0.02% | +1500.0% |
| Q1 2014 | $644,000 | -13.0% | 6,191 | -13.8% | 0.00% | 0.0% |
| Q4 2013 | $740,000 | +103.3% | 7,181 | +4.6% | 0.00% | – |
| Q3 2013 | $364,000 | +600.0% | 6,865 | +491.3% | 0.00% | – |
| Q2 2013 | $52,000 | – | 1,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |